Red blood cells are the most abundant cells in your bloodstream, numbering roughly 25 trillion in an average adult, and their sole purpose is to shuttle oxygen from your lungs to every tissue in your body and help carry carbon dioxide back. Unlike most cells, mature human red blood cells have no nucleus, no mitochondria, and no DNA. They are, in a sense, biological delivery vehicles stripped down to the essentials: a flexible membrane packed with about 270 million molecules of hemoglobin each. That deceptively simple design underpins an intricate physiology that touches everything from altitude sickness to malaria resistance to the shelf life of donated blood.
Shape and Flexibility
A red blood cell looks like a disc pinched inward on both sides, a shape called a biconcave disc. That geometry is not just cosmetic. It maximizes the cell’s surface area relative to its volume, which speeds up the diffusion of oxygen and carbon dioxide across the membrane. The shape also makes the cell remarkably flexible. Red blood cells are about 7 to 8 micrometers across, but they routinely squeeze through capillaries barely half that wide. This deformability depends on a mesh of proteins just beneath the membrane: short actin filaments cross-linked by long, springy spectrin molecules form an elastic skeleton that lets the cell bend without breaking.1PubMed Central. Myosin IIA interacts with the spectrin-actin membrane skeleton to control red blood cell membrane curvature and deformability When that skeleton is defective, cells become rigid or oddly shaped, and trouble follows quickly.
How Red Blood Cells Are Made
Red blood cells originate in the bone marrow through a process called erythropoiesis. Early precursor cells look much like any other cell: they have a nucleus, organelles, and the usual molecular machinery. As they mature, something unusual happens. The developing cell expels its nucleus entirely, a step called enucleation, which involves an elaborate sequence of protein sorting, internal scaffolding remodeling, and controlled breakdown of nuclear material.2PubMed Central. New insights into the mechanisms of red blood cell enucleation: From basics to clinical applications The result is a young red blood cell called a reticulocyte, which still contains ribosomes and some residual organelles. Over the next day or two in the bloodstream, reticulocytes finish maturing by clearing out those remaining organelles and remodeling their membranes and protein content.3PubMed. Understanding terminal erythropoiesis: An update on chromatin condensation, enucleation, and reticulocyte maturation What emerges is the streamlined, nucleus-free cell that will circulate for roughly 120 days.
The trigger for ramping production up or down is oxygen availability. When your tissues sense low oxygen, a family of proteins called hypoxia-inducible factors, particularly HIF-2, switches on in the kidneys and liver. This drives the production of erythropoietin, the hormone that tells the bone marrow to make more red blood cells.4PubMed Central. Regulation of erythropoiesis by hypoxia-inducible factors The kidney is the body’s main oxygen sensor for this purpose, and specialized cells in the kidney’s tissue produce erythropoietin in direct response to dropping oxygen levels.5PubMed. Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells The system works as a feedback loop: more red blood cells improve oxygen delivery, which dials erythropoietin back down. In mice, researchers have also found that HIF activation in kidney tubule cells can paradoxically suppress erythropoietin by altering local oxygen consumption, hinting that the regulation is more nuanced than a simple on-off switch.6JCI Insight. Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin
Carrying Oxygen and Carbon Dioxide
Hemoglobin is the protein that does the heavy lifting. Each hemoglobin molecule has four subunits, and each subunit can bind one molecule of oxygen. In the lungs, where oxygen is plentiful, hemoglobin loads up. In your muscles and organs, where cells are consuming oxygen and producing carbon dioxide, hemoglobin lets go. This loading and unloading is not a passive process; it is tuned by several factors.
One of the most important regulators is a small molecule called 2,3-diphosphoglycerate, or 2,3-DPG, found almost exclusively inside red blood cells. Higher 2,3-DPG levels reduce hemoglobin’s grip on oxygen, making it easier for tissues to pull oxygen off the molecule. This becomes especially important in situations like anemia or high-altitude living, where the body needs to extract more oxygen from fewer red blood cells or thinner air.7PubMed Central. 2,3-Diphosphoglycerate: the forgotten metabolic regulator of oxygen affinity Acidity and temperature also influence how readily hemoglobin releases oxygen, a phenomenon known as the Bohr effect, which relies partly on specific amino acid residues on hemoglobin’s surface.8PubMed. Assessment of roles of surface histidyl residues in the molecular basis of the Bohr effect and of beta 143 histidine in the binding of 2,3-bisphosphoglycerate in human normal adult hemoglobin
Red blood cells also play a key role in getting rid of carbon dioxide. Most COâ‚‚ doesn’t travel dissolved in blood plasma; instead, an enzyme inside the red blood cell converts it into bicarbonate, which dissolves much more readily in the blood. When the blood reaches the lungs, the reverse reaction occurs, and the COâ‚‚ is exhaled. The speed at which bicarbonate crosses the red cell membrane through a chloride-bicarbonate exchange channel can actually limit how quickly COâ‚‚ leaves the blood in the lungs.9PubMed. Effects of red blood cell HCO3(-)/Cl- exchange kinetics on lung CO2 transfer: theory So the red blood cell is not just a passive vehicle; it actively processes the gas it is carrying.
Death, Recycling, and Iron
After about 120 days, a red blood cell is worn out. Its membrane has stiffened, its enzymes have dwindled, and its surface has changed. One signal that marks an aging red blood cell for removal is a decline in a surface protein called CD47, which acts as a “don’t eat me” signal to immune cells. The oldest red blood cells in circulation carry roughly 30 percent less CD47 than the youngest, gradually losing the protection that kept them circulating.10PubMed. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation
When CD47 drops low enough, macrophages in the spleen (and to some extent the liver) engulf and digest the old cells. This is where iron recycling becomes critical. Each hemoglobin molecule contains iron at its core, and the body cannot afford to waste it. Splenic macrophages are specially equipped with proteins to break down hemoglobin, extract its iron, and export it back into circulation through a transporter called ferroportin.11PubMed. Macrophages and Iron Metabolism This export step is tightly controlled by a liver-produced hormone called hepcidin: when hepcidin levels are high, ferroportin is degraded and iron stays locked inside the macrophage, reducing iron availability for new red blood cell production.12PubMed Central. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin This hepcidin-ferroportin axis is a central reason why chronic inflammation can cause anemia even when iron stores are technically adequate: the iron is there, but the body won’t release it.
Blood Types and Disease Resistance
The surface of every red blood cell is studded with sugar molecules and proteins that define your blood type. The ABO system, the most familiar, is determined by which sugar-modifying enzymes your genes encode. Some of the most common enzyme variations in humans form the basis of blood group differences, and those differences have real consequences beyond transfusion compatibility.13PubMed Central. ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies
One of the most studied links is between blood type and malaria. The parasite that causes the most lethal form of malaria, Plasmodium falciparum, reproduces inside red blood cells and causes infected cells to stick to uninfected ones in clumps called rosettes. Rosetting is associated with severe disease. Critically, group O red blood cells form smaller rosettes than group A, B, or AB cells, and people with blood type O are significantly less likely to develop severe malaria.14PubMed Central. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting A large genetic study put numbers to this: people with non-O blood types faced roughly 49 percent greater risk of severe malaria, with the BB and AB genotypes carrying the highest risk, about double compared to OO.15PLOS Genetics. Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria This selective pressure from malaria likely explains why type O is so common in populations historically exposed to the disease, especially in sub-Saharan Africa.
When Red Blood Cells Go Wrong
Several inherited conditions alter red blood cell structure or hemoglobin composition with serious consequences. In sickle cell disease, a single amino acid change in hemoglobin causes the protein to polymerize into stiff fibers when oxygen levels drop. This deforms the cell into a rigid crescent shape that can block small blood vessels, causing sudden episodes of severe pain and organ damage.16PubMed Central. Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease Most drugs currently being tested for sickle cell disease target the downstream consequences of this sickling rather than preventing the polymerization itself, though newer approaches are trying to tackle the root cause directly.17PubMed Central. Treating sickle cell disease by targeting HbS polymerization
Thalassemias are another major group of red blood cell disorders. In alpha-thalassemia, reduced production of one type of hemoglobin chain creates an imbalance that leads to shortened red blood cell survival, chronic anemia, and a cascade of complications.18PubMed. Alpha-thalassemia: A practical overview In beta-thalassemia, the problem is flipped: too little beta-globin means excess alpha-globin chains accumulate and precipitate inside developing red cells, damaging them before they ever reach the bloodstream.19PubMed Central. Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice Both conditions are inherited, both are common in populations where malaria is or was endemic, and both represent nature’s imperfect compromise: carrying one copy of these mutations can offer some malaria protection, while inheriting two copies causes disease.
Enzyme deficiencies also matter. The most common red blood cell enzyme deficiency worldwide affects glucose-6-phosphate dehydrogenase, or G6PD. This enzyme protects the cell against oxidative stress. Without enough of it, certain foods, infections, or medications can trigger a burst of red blood cell destruction. G6PD deficiency also affects the quality of stored blood for transfusion, with G6PD-deficient red blood cells showing increased breakdown during storage and reduced survival after transfusion compared to normal cells.20PubMed Central. Impact of G6PD status on red cell storage and transfusion outcomes
Beyond genetic conditions, nutritional deficiencies can also alter red blood cells. Iron deficiency is the most well-known cause of anemia, but deficiencies in folate and vitamin B12 cause a different kind of problem: abnormally large red blood cells, a condition called macrocytosis. In a study of middle-aged and older adults, clinically significant macrocytosis appeared in about 8 percent of participants, and was independently associated with low folate, low B12, heavy alcohol intake, smoking, and thyroid problems.21PLOS ONE. Haematinic Deficiency and Macrocytosis in Middle-Aged and Older Adults A standard blood test that flags abnormally large or small red cells can be one of the earliest clues that something is off nutritionally, even before full-blown anemia develops.
Red Blood Cells Across the Animal Kingdom
Mammals are unusual in producing red blood cells that eject their nuclei. Birds, reptiles, amphibians, and fish all retain nucleated red blood cells. This raises an obvious question: why did mammals evolve to throw the nucleus away? One leading idea is that removing the nucleus frees up space for more hemoglobin and allows the cell to be more flexible, both of which could be advantages for animals with high metabolic rates. But research comparing birds and mammals has found no clear difference in hemoglobin concentration per cell between the two groups, even after accounting for evolutionary relationships, suggesting that nucleated and enucleated red blood cells may represent different solutions to the same oxygen-delivery challenge rather than one being strictly superior.22PubMed. Revisiting the question of nucleated versus enucleated erythrocytes in birds and mammals
Nucleated red blood cells are not metabolically inert. In reptiles and birds, these cells retain functional metabolic pathways including an active citric acid cycle, which gives them capabilities that mammalian red cells lack, such as the ability to reduce damaged hemoglobin using multiple enzyme systems.23Comparative Biochemistry and Physiology Part B: Comparative Biochemistry. Methaemoglobin and its reduction in nucleated erythrocytes from reptiles and birds Mammalian red blood cells, by contrast, rely almost entirely on simple sugar breakdown for their limited energy needs, having given up mitochondria along with the nucleus.
High altitude has produced some of the most striking evolutionary adaptations in hemoglobin. In birds, there is a remarkably strong correlation between native elevation and increased hemoglobin-oxygen affinity: species that live at high altitudes have evolved hemoglobin that grabs oxygen more tightly in the thin air of the lungs, compensating for reduced atmospheric pressure. The pattern in mammals is more equivocal, possibly because mammals rely more on other compensatory mechanisms like ventilation rate and capillary density.24PubMed Central. Hemoglobin–oxygen affinity in high-altitude vertebrates: is there evidence for an adaptive trend? Bar-headed geese, which migrate over the Himalayas, are a particularly famous example: their hemoglobin has specific amino acid substitutions that increase oxygen affinity, one of the most compelling cases of convergent biochemical adaptation in vertebrates.
Red Blood Cells as Parasites’ Targets
Malaria is the most notorious infection that exploits red blood cells, but it is not the only one. Babesia species, tick-borne parasites that cause a disease sometimes called “the malaria of the temperate world,” also invade and multiply inside red blood cells. Once inside, these parasites export proteins that remodel the host cell to suit their needs, making the red blood cell more hospitable for parasite growth and survival.25PubMed Central. Advances in understanding red blood cell modifications by Babesia The fact that red blood cells lack a nucleus and most immune-signaling machinery makes them a kind of immunological blind spot. The parasites essentially hide inside a cell the immune system is not well equipped to inspect from the outside, which is one reason these infections can be so persistent and difficult to clear.
What Happens to Donated Blood in Storage
If you have ever donated blood, those red blood cells were likely refrigerated in a bag of preservative solution and stored for up to 42 days. During that time, the cells undergo a slow deterioration collectively known as the storage lesion. Their 2,3-DPG levels plummet, which means stored red blood cells initially cling to oxygen more tightly and deliver it less efficiently than fresh cells. ATP levels also fall, and with them the cell’s ability to maintain its flexible disc shape. Stored cells gradually stiffen, shed tiny membrane fragments, and release free hemoglobin into the surrounding solution.26PubMed Central. Red blood cell storage lesion These changes can affect how well transfused red blood cells actually oxygenate tissues and may contribute to complications in recipients.27PubMed. Red blood cell storage lesion The clinical significance of the storage lesion has been debated for decades, and large randomized trials have generally found that older stored blood performs comparably to fresher blood for most patients, though the biology suggests that certain vulnerable populations may be more sensitive to these changes.
Red Blood Cells in Drug Delivery and Bioengineering
The same properties that make red blood cells good at their natural job have caught the attention of bioengineers. Red blood cells are biocompatible (the immune system tolerates them), biodegradable, and they circulate for months. Researchers have been developing drug delivery systems that wrap nanoparticles in red blood cell membranes, essentially disguising synthetic particles as red blood cells so they can circulate longer and avoid being cleared by the immune system.28PubMed Central. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application In animal models, these membrane-coated nanoparticles circulate far longer than uncoated ones and have been explored for applications ranging from cancer treatment to detoxification.29PubMed. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles
A separate line of research aims to create synthetic oxygen carriers for situations where blood transfusion is not available. These hemoglobin-based oxygen carriers use various forms of hemoglobin packaged outside of natural red blood cells to deliver oxygen. Several have gone through clinical testing, but none have yet received approval for human use in the United States, largely because early versions caused blood pressure spikes and other side effects when free hemoglobin scavenged nitric oxide from blood vessel walls.30PubMed Central. Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules Newer designs use cross-linked, polymerized, or encapsulated forms of hemoglobin to avoid these problems, and the field remains active. The appeal is obvious: a shelf-stable, universally compatible oxygen carrier could transform emergency medicine and battlefield care, where matching blood types and maintaining a cold chain are constant challenges.